SciELO - Scientific Electronic Library Online

vol.43 issue2Occurrence of Cryptococcus neoformans in pigeon excrement in the city of Pelotas, State of Rio Grande do SulCandida dubliniensis does not show phospholipase activity: true or false? author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links


Revista da Sociedade Brasileira de Medicina Tropical

Print version ISSN 0037-8682


VALENTE, Maria do Socorro da Silva  and  VIEIRA, José Luiz Fernandes. Thalidomide used by patients with erythema nodosum leprosum. Rev. Soc. Bras. Med. Trop. [online]. 2010, vol.43, n.2, pp.201-204. ISSN 0037-8682.

INTRODUCTION: Thalidomide is a drug currently used in Brazil for treating erythema nodosum leprosum. METHODS: This was a prospective study to follow up clinical evolution, record adverse events and determine plasma thalidomide levels from a dose of 100 mg/day, among 20 patients with clinical manifestations of erythema nodosum leprosum, divided into two groups: during or after leprosy multidrug therapy. RESULTS: No significant differences between the groups were seen during the study, either in relation to favorable clinical evolution among the patients (70% and 90%), or in relation to the adverse events recorded, which were dizziness and somnolence. The plasma thalidomide levels on D7 and D14 were 0.82 ± 0.4μg/ml and 0.79 ± 0.3 μg/ml in group 1 and 0.82 ± 0.4 and 1.55 ± 1.0 in group 2, respectively. CONCLUSIONS: In this sample, the multidrug therapy had no effect on the clinical evolution, incidence of adverse events and plasma thalidomide levels.

Keywords : Thalidomide; Erythema nodosum leprosum; Leprosy.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License